Viral Vector Separation Using Volatile Buffer Chromatography

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for characterizing viral vectors in gene therapy are inadequate for distinguishing between vectors containing targeted genetic material and those that are empty or contain non-targeted genetic material, particularly due to low packaging efficiency and storage-related issues, and these methods are not compatible with mass spectrometry analysis.

Innovation Solution

A method involving anion exchange chromatography using a volatile pH gradient mobile phase system with buffer solutions containing ammonium bicarbonate, ammonium hydroxide, acetic acid, and formic acid, which separates viral vectors based on their genetic content, allowing for detection using mass spectrometry.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional chromatography methods are used to separate viral vectors, then separation of vectors containing genetic material from empty vectors is achieved, but compatibility with mass spectrometry detection is lost due to non-volatile buffer salts

Engineering Contradiction:
Improvedetection accuracyVSAvoidmass spectrometry compatibility
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameters of the mobile phase by using volatile buffer salts (ammonium bicarbonate, ammonium hydroxide, acetic acid, formic acid) instead of conventional non-volatile buffer salts. This parameter change enables the mobile phase to be compatible with mass spectrometry detection while maintaining the separation capability of the chromatography system.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent substitutes the conventional detection system with mass spectrometry detection. By replacing the detection mechanism and using volatile buffers that evaporate cleanly, the system enables accurate mass spectral analysis of viral vectors while maintaining separation functionality.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Manufacturing precision

If non-volatile buffer salts are used in the mobile phase, then effective separation of viral vectors is achieved, but contamination risks increase and system sensitivity decreases

Engineering Contradiction:
Improveseparation efficiencyVSAvoidcontamination risk
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent changes the volatility parameter of the buffer salts from non-volatile to volatile. This change allows the buffer components to evaporate completely during mass spectrometry analysis, eliminating contamination risks and maintaining system sensitivity while preserving effective separation of viral vectors.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If a single buffer solution is used in the mobile phase, then system simplicity is maintained, but separation resolution of different viral vector types is insufficient

Engineering Contradiction:
Improvemobile phase complexityVSAvoidseparation resolution
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent segments the mobile phase into multiple buffer solutions (ammonium bicarbonate, ammonium hydroxide, acetic acid, and formic acid buffers) that can be used individually or in combination. This segmentation allows flexible gradient elution programs to achieve high separation resolution for different viral vector types while maintaining volatile components for mass spectrometry compatibility.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements dynamic gradient elution by varying the proportions of different volatile buffer solutions over time. This dynamic approach enhances separation resolution for complex viral vector mixtures while all buffer components remain volatile and compatible with mass spectrometry detection.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively separates and characterizes full and empty viral vectors, providing enhanced information through mass spectrometry, including accurate mass data and structural insights, while maintaining system sensitivity and avoiding contamination risks.

Implementation Method 1

Ion exchange chromatography (IEC) is a widely used analytical technique for the chemical analysis and separation of charged molecules. IEC involves the separation of one or more analyte species from other matrix component present in a sample. The analytes are typically ionic so that they can have an ionic interaction with a stationary phase.

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 2

When using a pH gradient elution, the pH of the eluent modifies the charge of the analyte and in turn changes the binding of the analyte to the stationary phase.

Methodology Applied
Scientific EffectpH gradient elution:

Implementation Method 3

Examples of some typical detectors are a conductivity detector, a UV-VIS spectrophotometer, and a mass spectrometer.

Methodology Applied
Scientific EffectMass spectrometry:

Data Source

PatentUS11821000B2Method of separating viral vectors
Publication Date: 2023.11.21 DIONEX CORP
  • US11821000B2 patent drawing
  • US11821000B2 patent drawing
  • US11821000B2 patent drawing

AI summary

A method of separating a liquid sample containing viral vectors includes flowing the liquid sample into an anion exchange column. A first viral vector contains a targeted genetic material and a second viral vector contains essentially no genetic material or a non-targeted genetic material, wherein the targeted genetic material is different than the non-targeted genetic material. A mobile phase can be flowed into the anion exchange column, wherein the mobile phase includes a buffer solution A and a buffer solution B. The buffer solutions A and B both include volatile buffer salts. The first viral vector and the second viral vector can be separated so that the first viral vector and the second viral vector elute off the anion exchange column at different times and then be detected.